Status: Not yet recruiting
A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants
The purpose of this study is to evaluate the metabolism, the routes and extent of elimination, and drug levels of \[14C\]Navlimetostat (BMS-986504) in healthy female participants
Participants needed: 6
Trial details
Phase: Phase 1Age: 18-55Biological sex: FemaleType: InterventionalSponsor: Bristol-Myers SquibbUpdated: Aug 20, 2026Locations: 2
Eligibility criteria
Participants must have a body mass index (BMI) of 18.0 to 35.0 kg/m2, inclusive. [+2]
Participants must not have any significant acute or chronic medical illness. [+3]